Delivery Order SPE2DB25D3020-SPE2DB25FWHCD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,323.44 to AmerisourceBergen Drug Corp for Annovera vaginal rings on March 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of March 12, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain....
- The Defense Logistics Agency awarded a delivery order valued at $4,754.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract demonstrates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings, valued at $8,469.84 under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,295.78 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA and is being performed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,620.00 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.04 to AmerisourceBergen Drug Corp for Annovera vaginal rings, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, indicating it flows from a larger indefinite delivery contract vehicle. The contraceptive product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,570.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $2,387.01 to AmerisourceBergen Drug Corp for Annovera vaginal rings. This is a firm fixed-price, competitively awarded contract with a completion date of September 23, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHCDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,484.60 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. As a non-set-aside competitive award, this delivery order demonstrates AmerisourceBergen's continued capability to meet federal medical procurement requirements through open competition. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and other critical medical commodities. Through this IDC framework, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and the U.S. Coast Guard, positioning itself as a key pharmaceutical supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/22/25 |